<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d4c/5187949/d8d34677666a/ijms-17-02149-g002.jpg"/> </div> <div class="text-side"> <h1>Dermal Delivery of Constructs Encoding Cre Recombinase to Induce Skin Tumors in Pten(LoxP/LoxP);Braf(CA/+) Mice.</h1> <p>Dermal delivery of Cre recombinase-expressing constructs under the control of the non-specific CAG promoter in PtenLoxP/LoxP;BrafCA/+ mice led to tumor formation. Tumors were induced in 4–10-week-old PtenLoxP/LoxP;BrafCA/+ mice by intradermal injection of lentiviral particles containing Cre recombinase DNA-expressing vectors or the direct delivery of constructs encoding the Cre recombinase DNA by tattoo administration or particle-mediated gene transfer, according to the protocols described under the Materials and Methods. (A) Schematic representation of intradermal injection of lentiviral particles; (B) Macroscopic image and microphotographs of H&amp;E and S100 and keratin 1 staining of a representative Schwannoma-like tumor; (C) Schematic representation of DNA tattoo administration; (D) Macroscopic picture and H&amp;E and S100 and keratin 1 staining of a representative Schwannoma-like tumor; (E) Schematic representation of particle-mediated gene transfer; and (F) Macroscopic picture and H&amp;E and S100 and keratin 1 staining of a representative atypical keratoacanthoma. Scale bars: 2.5×: 500 µm; 40×: 20 µm (B,D,F).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27999416/" target="_blank">27999416</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>